What should I do if I develop a painful rash after taking targeted therapy for lung cancer?
Apr 29, 2023
Source: Cainiu Health
Dr. Sun Qifeng
Introduction
In general, if a lung cancer patient develops painful skin rashes after taking targeted therapy drugs, symptomatic treatment can be provided according to the severity of the condition. Targeted drugs are medications designed to act on specific genetic mutations in a patient's tumor. If a lung cancer patient experiences any adverse symptoms during treatment, it is recommended to seek medical attention promptly to avoid delaying treatment and prevent unpredictable complications.
In general, when a lung cancer patient develops painful rashes after taking targeted therapy drugs, symptomatic treatment can be provided based on the severity of the condition. The specific analysis is as follows:
1. Mild rash
Targeted therapy drugs are medications designed to act on specific genetic mutations in a patient's tumor. In patients with particular constitutions, these drugs may trigger allergic reactions such as red papules, pustules, and itching. If the pain is mild and the rash covers only a small area, the patient may continue using the targeted drug while applying topical treatments such as chlorpheniramine hydrochloride cream or erythromycin ointment under a doctor’s guidance.
2. Moderate rash
If the patient experiences frequent pain, widespread red papules and pustules, or noticeable itching, it is recommended to adjust the dose of the targeted drug under medical supervision. Additionally, the patient should follow the doctor’s instructions to use medications such as tacrolimus ointment or minocycline hydrochloride capsules for treatment.
3. Severe rash
If the patient experiences severe pain, with extensive red papules and pustules covering large areas of the body, accompanied by symptoms like itching and tenderness, it is advised to immediately discontinue the targeted therapy drug and begin treatment with medications such as desloratadine oral solution or doxycycline hydrochloride enteric-coated capsules under a doctor’s direction.
If lung cancer patients experience any discomfort during treatment, they should seek timely medical attention to avoid delays in management and prevent potentially serious consequences.
